• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌和卵巢癌易感性的倾向性检测。

Predisposition testing for breast and ovarian cancer susceptibility.

作者信息

Calzone K A

机构信息

Cancer Risk Evaluation Program, University of Pennsylvania Cancer Center, Philadelphia 19104, USA.

出版信息

Semin Oncol Nurs. 1997 May;13(2):82-90. doi: 10.1016/s0749-2081(97)80004-6.

DOI:10.1016/s0749-2081(97)80004-6
PMID:9114475
Abstract

OBJECTIVES

To provide an overview of breast cancer predisposition syndromes and the breast and Ovarian cancer susceptibility genes identified to date. To describe the clinical implications of genetic testing for breast and ovarian cancer susceptibility.

DATA SOURCES

Published research and educational manuscripts, books, conference proceedings, and personal experiences.

CONCLUSION

Nurses must become knowledgeable of predisposition genetic testing for inherited breast cancer risk including: understanding of the gene being analyzed and associated cancer risks, indications for testing, the limitations of the test, the management options for mutation carriers, risks and benefits of testing, and the long-term psychosocial sequelae.

IMPLICATIONS FOR NURSING PRACTICE

Predisposition testing for alterations in breast cancer susceptibility genes is rapidly moving into the general oncology and primary care community where nurses will play a major role in the provision of genetic services. The role of nursing in cancer genetics includes practice and education, nursing research, and policy initiatives.

摘要

目标

概述乳腺癌易感综合征以及迄今已鉴定出的乳腺癌和卵巢癌易感基因。描述乳腺癌和卵巢癌易感性基因检测的临床意义。

数据来源

已发表的研究和教育手稿、书籍、会议论文集以及个人经验。

结论

护士必须了解遗传性乳腺癌风险的易感基因检测,包括:了解所分析的基因及相关癌症风险、检测指征、检测局限性、突变携带者的管理选择、检测的风险和益处,以及长期的心理社会后果。

对护理实践的启示

乳腺癌易感基因改变的易感检测正迅速进入普通肿瘤学和初级保健领域,护士将在提供基因服务方面发挥主要作用。护理在癌症遗传学中的作用包括实践与教育、护理研究以及政策倡议。

相似文献

1
Predisposition testing for breast and ovarian cancer susceptibility.乳腺癌和卵巢癌易感性的倾向性检测。
Semin Oncol Nurs. 1997 May;13(2):82-90. doi: 10.1016/s0749-2081(97)80004-6.
2
Predisposition testing for inherited breast cancer.遗传性乳腺癌的易感性检测
Oncology (Williston Park). 1998 Aug;12(8):1227-41; discussion 1241-2.
3
BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes.BRCAPRO验证、BRCA1/BRCA2基因检测的敏感性以及其他乳腺癌易感基因的患病率。
J Clin Oncol. 2002 Jun 1;20(11):2701-12. doi: 10.1200/JCO.2002.05.121.
4
Prevention and therapy for BRCA1/2 mutation carriers and women at high risk for breast and ovarian cancer.BRCA1/2 基因突变携带者以及乳腺癌和卵巢癌高危女性的预防与治疗。
Eur J Cancer Prev. 2000 Jun;9(3):139-50.
5
[Clinical and molecular diagnosis of inherited breast-ovarian cancer].遗传性乳腺癌-卵巢癌的临床与分子诊断
J Gynecol Obstet Biol Reprod (Paris). 2003 Apr;32(2):101-19.
6
Breast & ovarian cancer. Issues in risk assessment.乳腺癌与卵巢癌。风险评估问题。
Adv Nurse Pract. 1999 Aug;7(8):26-32; quiz 33-4.
7
Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.关于采用预测试教育方法以增强BRCA1基因检测知情决策的对照试验。
J Natl Cancer Inst. 1997 Jan 15;89(2):148-57. doi: 10.1093/jnci/89.2.148.
8
Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force.乳腺癌和卵巢癌易感性的遗传风险评估及BRCA突变检测:美国预防服务工作组的系统证据综述
Ann Intern Med. 2005 Sep 6;143(5):362-79. doi: 10.7326/0003-4819-143-5-200509060-00012.
9
Psychosocial aspects of genetic counseling and testing.遗传咨询与检测的社会心理层面
Semin Oncol Nurs. 2004 Aug;20(3):186-95. doi: 10.1053/j.soncn.2004.04.005.
10
BRCA1 genetic mutation and its link to ovarian cancer: implications for advanced practice nurses.BRCA1基因突变及其与卵巢癌的关联:对高级执业护士的启示
J Am Acad Nurse Pract. 2005 Dec;17(12):518-26. doi: 10.1111/j.1745-7599.2005.00091.x.